Internal Medicine Doctors in Corinth, MS Accepting Medicare

64 Internal Medicine doctors found. Showing 61 - 64

Lindsey Bedford, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000

Adnan Zafar, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000

Dr. Matthew T Tipton, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 423-914-9162

Dr. Oneka Y. Richardson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-415-9980

News Archive

People consuming energy drinks while not exercising put themselves at risk

Researchers have found that more people are making themselves vulnerable to health problems by downing sports energy drinks that are meant to be used with intense exercise – while sitting around.

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE 2 Phase I/IIa study indicate that treatment with four weeks of the Company's investigative immune-modulator, recombinant human Interleukin-7, added to peginterferon and ribavirin in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC, induces a broad immune response associated with HCV viral clearance in genotype 1 and 4 treatment experienced patients defined as nonresponders to SOC.

Sumitomo receives FDA 510(k) clearance for Proton Therapy System

Sumitomo Heavy Industries, Ltd. announced today that it had received US FDA 510(k) clearance of its Proton Therapy System. It is the first 510(k) cleared medical device for Sumitomo. Proton therapy is a form of radiation therapy, which employs proton beams to kill cancer cells with better dose distribution in comparison with conventional x-rays. Currently 12 facilities are operational and several more are under construction in the United States, and the U.S. proton therapy market is expected to expand in the future.

Tufts CSDD: Orphan product designations increased up to 425 in 2006-08

The number of orphan product designations in the U.S. more than doubled during the last decade, reflecting growing interest by pharmaceutical and biotech companies in developing products to treat orphan diseases, according to a study recently completed by the Tufts Center for the Study of Drug Development.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4(current)